Size

200ul

Catalog no#

MBS642950

Price

603 EUR

Additional isotype

IgE

Gene name

N/A

Gene name synonims

N/A

Immunoglobulin isotype

IgG

Concentration

N/A

Species reactivity

Mouse

Specificity and cross-reactivity

Mouse

Alternative name4

Lgals3

French translation

anticorps

Category

Antibodies

Clonality

Polyclonal

Clone

Polyclonal antibody

Host organism

Host: Rabbit; Source: Mouse

Tested for:

ELISA (EL/EIA), Western Blot (WB)

Purification method

Affinity Purified by Protein A affinity chromatography.

Form/Appearance

Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.

Other gene names

LGALS3; LGALS3; L31; GAL3; MAC2; CBP35; GALBP; GALIG; LGALS2; N/A

Additional description

Antigens are peptides or recombinant or native dependent on the production method.

Alternative name2

Lgals3, ID (Lgals3, Galectin-3, 35kD lectin, Carbohydrate-binding protein 35, Galactose-specific lectin 3, IgE-binding protein, L-34 galactoside-binding lectin, Laminin-binding protein, Lectin L-29, Mac-2 antigen)

Alternative name1

Anti-Lgals3, ID (Lgals3, Galectin-3, 35kD lectin, Carbohydrate-binding protein 35, Galactose-specific lectin 3, IgE-binding protein, L-34 galactoside-binding lectin, Laminin-binding protein, Lectin L-29, Mac-2 antigen)

Alternative name5

Anti -Lgals3, ID (Lgals3, Galectin-3, 35kD lectin, Carbohydrate-binding protein 35, Galactose-specific lectin 3, IgE-binding protein, L-34 galactoside-binding lectin, Laminin-binding protein, Lectin L-29, Mac-2 antigen)

Other names

LGALS3; Galectin; galectin-3; lectin L-29; 35 kDa lectin; MAC-2 antigen; IgE-binding protein; laminin-binding protein; galactose-specific lectin 3; carbohydrate-binding protein 35; lectin, galactoside-binding, soluble, 3; N/A

Alternative name3

Lgals3, ID (Lgals3, Galectin-3, 35kD lectin, CarbohydRattus norvegicuse-binding protein 35, Galactose-specific lectin 3, IgE-binding protein, L-34 galactoside-binding lectin, Laminin-binding protein, Lectin L-29, Mac-2 antigen)

Storage and shipping

Store at 4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, productone should be kept at -20 degrees Celsius. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Advisory

In order to retain the quality and the affinity of productone unchanged, please, avoid cycles of freezing and thawing. For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube. Prior to use briefly centrifuge the vial to gather all the solution on the bottom.

Description

productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against. Properly used, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in. Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, they are inexpensive to manufacture and respectively to buy, the time needed for production is considerably shorter. Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions. To obtain more detailed information on productone, please, refer to the full product datasheet.

Properties

If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Immunoglobulin E (IgE) kappa or Fc specific antibody is a kind of antibody (or immunoglobulin (Ig) "isotype") that has only been found in mammals. IgE is synthesized by plasma cells. Monomers of IgE consist of two heavy chains (ε chain) and two light chains, with the ε chain containing 4 Ig-like constant domains (Cε1-Cε4). IgEs play a role in allergy and response to parasite infection. High levels of IgEs caused by parasites can lower the allergic reaction of patients to allergens common present in the human environment. As such the parasite history of an allergic patient needs to be taken in consideration as a positive factor.